Annotated Medicine and Device Lists

Oseltamivir

Capsule 30 mg (as phosphate) Capsule 45 mg (as phosphate) Capsule 75 mg (as phosphate) Powder for oral administration 20 mg/5 mL Powder for oral liquid 12 mg/mL Tablet 75 mg

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.
Cuba	6.4 Antivirales	No observations

This medicine is present in:

List	Section	Observation
Cuba	6.4 Antivirales	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.6.2. Other Antivirals	Others observations: According to the 20th World Health Organization Model List of Essential Medicines published in March 2017, Oseltamivir is indicated for severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.6.2. Other Antivirals	Others observations: According to the 20th World Health Organization Model List of Essential Medicines published in March 2017, Oseltamivir is indicated for severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.

Information Resources: Oseltamivir

No information available